Primary study · included by 1 review

Clinical, radiographic, and histological evaluation of three different pulp-capping materials in indirect pulp treatment of primary teeth: a randomized clinical trial.

Sahin 2021 · Sahin Nur, Saygili Suna, Akcay Merve · Clinical oral investigations · 2021

Included by

Resin-Modified Calcium Silicate-Based Materials Versus Conventional Formulations in Primary Teeth: A Systematic Review and Meta-Analysis of Clinical and Radiographic Outcomes of Vital Pulp Therapy Procedures in Pediatric Dentistry.

Non-Cochrane · intervention · 2026 · cited as Sahin 2021 · Table 2; Reference 42

Outcome this study informs	Pooled effect	Evidence	Certainty
Overall clinical and radiographic success TheraCal LC (resin-modified calcium silicate) for indirect pulp capping vs Non-resin calcium silicate materials (MTA ProRoot, MTA Angelus, Biodentine) · >=360 days	RR 0.94 [0.86, 1.03]	2 studies · 153 participants	Low
Overall clinical and radiographic success TheraCal LC (resin-modified calcium silicate) in vital pulp therapy (ipc, dpc, pulpotomy) vs Non-resin calcium silicate materials (MTA ProRoot, MTA Angelus, Biodentine) · <360 days	RR 0.99 [0.96, 1.02]	7 studies · 400 participants	Low
Overall clinical and radiographic success TheraCal LC (resin-modified calcium silicate) for indirect pulp capping vs Non-resin calcium silicate materials (MTA ProRoot, MTA Angelus, Biodentine) · <360 days	RR 0.99 [0.95, 1.03]	5 studies · 218 participants	Low
Overall clinical and radiographic success TheraCal LC (resin-modified calcium silicate) in vital pulp therapy (ipc, dpc, pulpotomy) vs Non-resin calcium silicate materials (MTA ProRoot, MTA Angelus, Biodentine) · >=360 days	RR 0.95 [0.89, 1.01]	5 studies · 355 participants	Low

1 including review in total.